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The problem of arterial disease associated with diabetes mellitus has loomed 
larger and larger ever since the discovery of insulin.  However, experimental 
study of this problem has been thwarted by the fact that dogs and cats,  in 
which experimental diabetes can be readily produced by several methods, are 
notoriously resistant to the development of arterial disease.  On the other hand, 
although experimental arterial diseases of various types can be produced very 
easily in rabbits, this species  cannot be rendered permanently diabetic by an- 
terior pituitary extracts and its pancreatic tissue, like that of other rodents, has 
an anatomical distribution such as to render total pancreatectomy an operation 
of extreme technical difficulty.  Thus, prior to the recognition of the diabeto- 
genie properties of alloxan, it was not feasible to study experimentally the effects 
of diabetes in the one mammalian species that appeared most likely to respond 
to such a metabolic disturbance with the development of some form of arterial 
disease.  The discovery that rabbits can be rendered permanently diabetic by 
alloxan has made it possible to embark upon a study of the effects of diabetes on 
the arteries of rabbits with the hope of gathering experimental data that might 
have significance not only in relation to the problem of arteriosclerosis develop- 
ing in man in association with diabetes mellitus but also in relation to the larger 
problem of arteriosclerosis in general. 
The pathological changes encountered in the pancreas and in certain other tissues 
of animals rendered  diabetic  by pancreatectomy, by the administration of anterior 
pituitary extracts,  and by the injection of aUoxan have been reviewed elsewhere(1). 
In some of the earlier papers  dealing with alloxan diabetes  as observed in various 
species, it was stated that no changes in the arteries were found in association with 
this experimental  disease in spite  of the coexistence in some instances  of marked 
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lipemia, but the duration of these experiments was relatively short.  The occurrence 
of visible lipemia in alloxan diabetes in rabbits lent support to the supposition that 
atherosclerosis  might develop in  them after a  suiticient  period of time, since  it is 
well known that the continued feeding  of cholesterol  to rabbits is followed by the 
appearance  of  lipemia,  hypercholesterolemia,  and  the  eventual  development  of 
experimental  cholesterol  atherosderosis(2--4).  Accordingly,  Duff  and  Wilson(5) 
carried out a series of experiments in which the blood cholesterol levels were followed 
during the course of prolonged aUoxan diabetes in rabbits with a view to determining 
at the end of the experiments whether any effect had been produced on the arterial 
system.  They found that lipemia was usually an evanescent phenomenon and in 
some cases  did  not  occur at  all.  The  blood  cholesterol  was  frequently  elevated 
for a time to values of about 350 mg. per cent but it almost always returned to normal 
in 3 to 6 weeks and so remained for the rest of the animal's life, in spite of the per- 
sistence  of more or less  severe diabetes as judged  by the continuance  of marked 
hyperglycemia, glycosuria,  polydypsia,  polyuria  etc.  In  these  experiments  they 
could  find  no evidence at autopsy of the  development of atherosclerosis  either in 
the aorta or other arteries of rabbits that had been diabetic for periods of time ranging 
from several months up to a maximum of 1 year. 
In view of the negative result just described, the experiment reported in Part I 
of the present communication was undertaken.  It was designed to permit of a 
comparison between the effects of cholesterol feeding in normal rabbits and in 
rabbits previously rendered diabetic by aUoxan.  The unexpected result of this 
experiment was the demonstration that the development of cholesterol athero- 
sclerosis  is markedly inhibited  in  alloxan-diabetic  rabbits as  compared with 
non-diabetic control animals, in spite of the fact that hypercholesterolemia of 
comparable degree is induced in the two groups of animals by cholesterol feed- 
ing.  This result has already been briefly recorded (6). 
The inhibition of the development of experimental cholesterol atherosclerosis 
in rabbits rendered diabetic by alloxan suggested the importance of determining 
whether the retrogressive changes that are known to occur in the arterial lesions 
after the feeding of cholesterol is terminated  (2,  3)  would be affected by the 
induction of alloxan diabetes at the completion of an adequate course of choles- 
terol feeding.  An account of an experiment carried out with this end in view is 
contained in Part II of the present paper. 
I.  Trm I~rmBrrioN oF  EXl,  Err~n~.NT~  CHOLESTEROL ATn~.ROSCLSROSIS 
IN  ALLOXAN DIABETES 
Materials and Methods 
The animals employed were young, adult,  domestic white rabbits of both sexes.  The 
ages of these animals were unknown.  They weighed from 2 to 3 kilos at the beginning of 
the experiment, and all were healthy, growing animals.  Housed in separate metal cages, 
they were given a diet of Purina rabbit chow and water at/libitura.  No dietary supplements 
were used.  The animals were divided into convenient groups or series, and after a  period 
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free and total cholesterol in the serum were made in the fasting state  by a  modification of 
Folin's micro  method,  and  by  the  Schoenheimer and  Sperry  method  respectively.  After 
establishing that these quantities were within normal limits, half of the animals were selected 
at random and were injected with a freshly prepared 5 per cent aqueous solution of alloxan 
(Eastman Kodak Co.) in the lateral ear vein.  The dose was 200 mg. per kilo of body weight. 
This treatment was followed by the daily injection of 2 to 6 units of protamine zinc insulin 
and of about 1 gm. of dextrose for a period of 7 to 14 days.  The animals were then left without 
further treatment for a period of 4 to 5 weeks in order to allow for stabilization of the meta- 
bolic processes, after which cholesterol feeding was instituted.  Urinary sugar and acetone 
estimations were  made when indicated.  Fasting blood sugar and cholesterol values were 
estimated at approximately biweekly intervals. 
The normal control and alloxan-injected animals in each series were fed exactly the same 
doses of cholesterol on the same days of the experiments and, except for the previously men- 
tioned period  of insulin and  dextrose  therapy,  were  treated exactly alike.  The animals of 
series 3  received dry powdered cholesterol in gelatin capsules, according to  the method of 
Pollak (7).  The animals of all other series received a 3.3 or 5 per cent solution of cholesterol 
in corn oil dissolved and maintained at 60°C. and fed by means of a stomach tube after cooling. 
The daily dose of cholesterol varied in the different experimental series from 0.25 to 0.75 gm. 
The details of the total amounts of cholesterol fed, and the durations of feeding in the various 
experimental series are shown in Table I. 
On completion of the period of cholesterol feeding the surviving animals were killed by 
air embolism, complete autopsies were performed, and the tissues were fixed  and sectioned. 
The aorta and heart were removed en bloc, fixed in formalin, stained in Sudan IV, and the 
fatty deposits in the infima revealed by this method were recorded on standardized, schematic 
drawings of the aorta.  The aorta was then severed from the heart, small blocks were removed 
for frozen sections, and the remainder was rolled into a coil and embedded in paraffin.  These 
blocks were sectioned in such a  manner that a single microscopic section included the entire 
length of the aorta.  The paraffin sections were stained with hematoxylin and eosin, Verhoeff- 
Van Gieson stain for elastic tissue, and Mallory's phosphotungstic acid hematoxylin.  Frozen 
sections of  the  aorta,  liver, spleen, and adrenal  gland were  examined after staining with 
Sudan  IV. 
The  maximum  values accepted  as  normal were:  blood sugar  160  rag.  per  cent,  total 
cholesterol 80 mg. per cent, and free cholesterol 35 mg.  per cent.  An animal was regarded 
as being diabetic if the fasting blood sugar average was 300 mg. per cent or greater, and if 
most of the obvious manifestations of alloxan diabetes, such as persistent polyuria, glyco- 
suria, polydipsia,  polyphagia, and  weight loss were  present.  In addition, the histological 
demonstration of the characteristic hydropic changes in the pancreas (8) and the lesion of 
Armanni in the kidney were taken as confirmatory evidence of the existence of a persistent 
diabetic state.  Certain of  the animals that had  received a  diabetogenic dose of alloxan, 
although they were initially diabetic, reverted to a  normal metabolic state by the time that 
cholesterol feeding was instituted and thereafter showed neither chemical nor obvious evidence 
of diabetes.  Such animals were classed as "alloxan-recovered"  (see Table I).  The degree 
of experimental cholesterol atherosclerosis observed in each animal was graded on an arbitrary 
scale of 0  to 4 as shown in Fig.  1.  It is important to note that atherosclerosis of grade 1 
severity was recorded even when only a  single fleck of lipid deposit was revealed by careful 
gross examination after Sudan staining of the entire aorta.  This gross grading was confirmed 
by  microscopic  examination.  The  amount  of  sudanophilic,  lipid  substance  in  the  liver, 
spleen, and adrenal was graded in a  similar arbitrary manner on a  scale of 0 to 4 by micro- 
scopic examination of stained, frozen sections.  A lipemic condition of the blood induced by 
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before and after dotting in ~itro.  A lipemic index for each animal was established by averag- 
ing the grades of lipemia observed on all the occasions when the blood was sampled. 
2  3  "~  0  1 
Fzo. 1.  The standard schematic diagram of the rabbit's aorta used for charting the ex 
tent of the atherosderosis observed at autopsy is illustrated.  The five diagrams represent 
the aortic lesions observed in five  animals and show, from left to right, the degrees of ather- 
osclerosis graded as 0, 1, 2, 3, and 4 respectively. 
Observations 
The observations are summarized in Table I.  Over 100 animals were used 
in this experiment, but the mortality rate from the use of alloxan and from feed- 
ing  and  other  accidents  was high.  Only the  58  animals  that  completed an 
experimental course of satisfactory duration are reported upon.  These com- 
prised  18  diabetic and 39 non-diabetic animals.  In addition,  there was one 
animal (No. 43) that showed a  moderate elevation of the blood sugar level in 
the postprandial state only, and is referred to in the table as mildly diabetic. 
The 39 non-diabetic animals comprised 13 rabbits that had recovered from the 
effects of a  diabetogenic dose of alloxan  ("alloxan-recovered" group), and 26 
normal control animals that were subjected to cholesterol feeding alone.  The 
period of cholesterol feeding varied from 52 to 91 days.  The total dose of cho- 
lesterol fed varied between 16 and 65 gin. and the average daily dose of choles- 
terol fed varied from 180 to 750 rag. among the different experimental series. 
The chemical values given in the table are arithmetical averages of biweekly 
determinations made during the period of cholesterol feeding and of one deter- 
ruination made immediately before cholesterol feeding was begun.  The very 
high maximum values obtained in some of the animals are not shown, but are, 
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The dosage of cholesterol and the duration of cholesterol feeding varied from 
those that induced neither a hypercholesterolemia nor cholesterol atherosclerosis 
among the control animals (series 1 and 2) to those that induced in the controls 
a  very severe degree of both, with the formation of confluent atherosclerotic 
lesions extending over the entire intimal surface of the aorta and measuring 
from one to one and one-half times the  thickness of the underlying media. 
However, inspection of the data in Table I reveals that there was a remarkable 
discrepancy in the degree of atherosclerosis induced in the diabetic animals as 
compared with that induced in the comparable groups of control rabbits fed 
exactly the same quantities of cholesterol within the same period of time (Figs. 
2 and 3).  In each experimental group, with the exception of series  1 and 2 in 
which no atherosclerosis was induced in any of the animals, the diabetic rabbits 
showed a striking resistance to the induction of experimental cholesterol athero- 
sclerosis of the aorta.  On the other hand, the control rabbits and the "alloxan- 
recovered" group presented the expected incidence and degree of cholesterol 
atherosclerosis without distinction.  The 23 control animals contained in series 
3 to 11 inclusive, all presented more or less severe atberosclerosis of the aorta. 
Of these 23 animals, 8 presented aortic atherosclerosis of grade 1 severity, 4 of 
grade 2, 4 of grade 3, and 7 of grade 4.  The 12 "alloxan-recovered" animals in 
these same series presented similar findings.  Of these 12 animals 1 showed no 
atberosclerosis, 2 had aortic lesions of grade 1 severity, 4 of grade 3, and 5 of 
grade 4.  In contrast to these results, the 13 diabetic animals in the same groups 
presented no atherosclerosis in 6 animals, grade 1 aortic lesions (usually mini- 
mal) in 6, and aortic atherosclerosis of grade 2 (minimal) in only 1 rabbit.  The 
quantities of sudanophilic lipid material present in the liver, spleen, and  ad- 
renals, in general, corresponded closely with that found in the aorta.  The dia- 
betic rabbits showed evidence of the same resistance to lipid deposit in the liver, 
spleen, and adrenals as in the aorta.  Indeed, some of the diabetic rabbits were 
completely protected from the deposition of cholesterol, as judged by careful 
morphological examination, not only in the aorta but also in these other organs. 
Most important is the observation that the diabetic state did not inhibit the 
development of a hypercholesterolemia that was as high as that induced in the 
corresponding "alloxan-recovered" and control animals and that was occasion- 
ally considerably higher (Figs. 2 and 3).  This was also true of both the free and 
ester fractions of the serum cholesterol; there was no significant alteration in 
the ratio of ester to total cholesterol content.  In addition to exhibiting an 
equally marked degree of hypercholesterolemia, the diabetic rabbits  showed 
a visible lipemia in vitro that was much more marked than that observed in the 
corresponding  non-diabetic  animals.  The  control  and  "alloxan-recovered" 
animals did not show more than a moderate to marked opalescence of the serum, 
while the diabetic animals exhibited a lipemia that was manifest as a milky or 
creamy appearance that rendered the serum opaque.  A further difference in 
the lipemia of the diabetic and non-diabetic animals was the rapidity with which TABLE I 
Summary of Experimental Data 
! Weight  Weight 
r Dura-  Total  at b~gln-  at ~om-  Aw,~, 
Exl~ri- i tion  of  dose  of  niug  of  pletlon ot  Sf~  Series  No.  Sex  mental  'cholee-  type*  terol  choles- eholes-  choles-  sugar 
i feeding  terol  terol  terol 
feeding  feeding 
Average Average 
free  total 
SeruH1  5erunl 
choles-choles- 
terol  terol 
rag. per rag. per  ~g. per 
days  gm.  kg.  kg.  cent  cent  cent 
1  M  D  2.98  2.61  508  68  114 
2  M  D  2.12  1.89  583  89  111 
3  M  D  91  16  2.74  2.92  397  13  32 
4  M  C  2.56  3.20  109  11  30 
5  M  AR  3.08  3.51  108  14  32 
6  M  D  2.53  2.24  501  51  71 
7  M  D  2.09  2.50  473  20  42 
90  31 
8  M  C  3.26  4.66  116  11  23 
9  M  C  3.09  3.75  115  24  55 
Grade 
of aor- 
Lipemic tic ath- 
index  ~ ero- 
(0-4)  scle- 
! 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
,0  i  0 
0  [  0 
0  0 
10  F  D  2.45  1.98  517  18  53  0  0 
11  M  D  3.15  2.64  472  45  90  0.8  0 
12  F  C  91  38  3.54  4.06  96  25  84  0  1 
13  F  C  (dry)  3.08  3.36  96  33  130  0  1 
14  M  C  2.84  2.76  100  27  103  0  :  1 
15  M  D 
16  M  C 
17  M  C 
18  M  AR 
19  M 
20  M 
21  F 
22  F 
23  F 
24  M 
25  M 
26  F 
27  F 
28  F 
29  M 
30  M 
31  F 
D 
D 
C 
C 
C 
AR 
D 
D 
C 
C 
AR 
AR 
AR 
52  39 
53  40 
90  46 
2.23  2.05  329  220  726  2  0 
2.28  2.63  136  41  120  1  1 
2.41  2.07  153  414  1728  1.3  3 
3.24  3.58  126  14  48  0  0 
I 
2.22  1.59  481  219  423  3.75[  0 
2.37  1.88  427  101  197  2.75  I  0 
4.58  5.15  119  64  210  0.5  1 
3.50  4.59  131  105  316  1  i 
3.02  3.72  129  111  389  1.5  2 
3.32  3.63  111  32  77  0.25  1 
I 
2.58  1.84  355  192  396  3.7  1 
2.73  2.60  354  57  159  1.7  !  1 
3.90  4.14  114  155  334  1.7  4 
3.62  4.40  123  139  349  2.0  4 
3.04  3.23  116  104  359  1.8  i  4 
3.43  3.78  108  89  232  1.2  4 
3.55  3.98  115  100  367  1.8  4 
32  M 
33  M 
34  M 
[ 35  M 
36  M 
37  M 
D 
C 
C 
C 
AR 
AR 
89  48.5 
3.48  3.45  452  99  277  2  1 
4.38  5~25  114  15  63  0  2 
3.40  3.68  118  66  167  1.4  3 
3.29  3.13  111  97  316  i 1.8  4 
4.45  4.99  110  59  140  1  3 
3.94  4.31  116  i  60  123  L 1  3 
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Series 
10 
11 
* D  =  diabetic; C =  control; AR =  "alloxan-recovered;" MD =  mild diabetic. 
this phenomenon became apparent after the blood was drawn.  Lipemia was 
apparent in the blood of diabetic animals within 1 to 20 minutes.  It was seldom 
seen in the blood of comparable non-diabetic animals before 30 to 60 minutes 
after the blood was drawn. 
While the data considered above are consistent, the variability of the choles- 
terol dosage and of the duration of the experiments precludes a detailed analysis 
of the possible influence of certain other experimental variables, such as sex and 
change in weight of the animals during the experiment.  It is interesting, there- 
fore, to compare the data of individual animals that were similar in as many 
respects as possible, in order to assess the importance of these factors.  The 
protocols of a  number of such animals are given below. 
The following protocols are of a diabetic rabbit and of a non-diabetic control 618  EZFECr OF DIABETES  ON CHOLESTEROL  ATHEROSCLEROSIS 
animal that are comparable as to sex and in all other respects, except that in the 
diabetic animal the degree of lipemia was much greater, and the amount of lipid 
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FIG. 2.  Diagram and graph illustrating the procedures  and findings in diabetic  rabbit 
50, series 10.  The aortic atherosclerosis shown was recorded as grade 1. 
deposition  in the aorta,  liver,  spleen,  and adrenal  was much less than  in the 
control rabbit. 
No. 38.  D~bet@.  Male.--Dose of cholesterol per day, 0l ~  gm.  Duration Of feeding, 
76 days.  Average total serum cholesterol,  401 rag. per cent.  Lipemic index, 4.0.  Ather- G.  L.  DUFF AND  G.  C.  MoMILLAN  619 
osclerosis, grade 0.  Liver fat, grade 0.  Splenic fat, grade 1.  Adrenal fat, normal.  Weight 
gain, 0.42  kilo. 
No. 39.  Control.  Made.--Dose of cholesterol  per day, 0.68  gin.  Duration of  feeding, 
76 days.  Average total serum cholesterol,  425 mg. per cent.  Lipemic index,  1.75.  At.her- 
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Fro.  3.  Diagram and  graph  illustrating  the  procedures and  findings in  non-diabetic 
control rabbit 52, series 10.  The aortic atheroselerosis shown was recorded as grade 4. 
osclerosis, grade 4.  Liver fat, grade 4.  Splenic fat, grade 3.  Adrenal fat, grade 4.  Weight 
gain, 0.56 kilo. 
The following  two  groups of protocols  in  which  the  comparable  diabetic, 
"alloxan-recovered,"  and  non-diabetic  control  animals  alternate  in  sex,  also 
indicate that sex is not the determining factor in inhibiting the deposition of 
lipids in the aorta and elsewhere. 520  EFFECT OF DIABETES ON CHOLESTEROL ATtu':ROSCLEROSIS 
No. 26.  Diabetic.  Female.--Dose of cholesterol per day, 0.52 gm.  Duration of feeding, 
90 days.  Average total serum cholesterol,  159 mg. per cent.  Lipemic index, 1.7.  Athero- 
sclerosis, grade 1.  Liver fat, grade 1.  Splenic fat, grade 1.  Adrenal fat, grade 1.  Weight 
loss, 0.13 kilo. 
No. 36.  "Alloxan-Recovered."  Mde.--Dose of cholesterol per day, 0.54 gm.  Duration 
of feeding, 89 days:  Average total serum cholesterol,  140 mg. per cent.  Lipemic index, 1. 
Atherosclerosis,  grade 3.  Liver fat, grade 3.  Splenic fat, grade 3.  Adrenal fat, grade 3. 
Weight gain, 0.54 kilo. 
No.  34.  Control.  Mage.--Dose of cholesterol  per day, 0.54 gin.  Duration of feeding, 
89 days.  Average total serum cholesterol,  167 rag. per cent.  Lipemic index, 1.4.  Ather- 
osclerosis, grade 3.  Liver fat, grade 2.  Splenic fat, grade 0.  Adrenal fat, grade 2.  Weight 
gain, 0.28 kilo. 
No. 25.  Diabetic.  Ma/e.--Dose of cholesterol  per day, 0.52 gm.  Duration of feeding, 
90 days.  Average total serum cholesterol,  396 rag. per cent.  Lipemic index, 3.7.  Ather- 
osclerosis, grade 1.  Liver fat, grade 1.  Splenic fat, grade 1.  Adrenal fat, normal.  Weight 
loss, 0.74 kilo. 
No. 29.  "Alloxan-Recovered."  Mde.--Dose of cholesterol per day, 0.52 gin.  Duration 
of feeding, 90 days.  Average total serum cholesterol, 359 rag. per cent.  Lipemic index, 1.8. 
Atherosclerosis,  grade 4.  Liver fat, grade 4.  Splenic fat, grade 3.  Adrenal fat, grade 4. 
Weight gain, 0.19 kilo. 
No. 31.  "Alloxan-Recovered."  Fema/e.--Dose of cholesterol per day, 0.52 gin.  Duration 
of feeding, 90 days.  Average total serum cholesterol, 367 rag. per cent.  Lipemic index, 1.8. 
Atherosclerosis, grade 4.  Liver fat, grade 1.  Splenic fat, grade 0.  Adrenal fat, grade 2. 
Weight gain, 0.43 kilo. 
No. 27.  Control.  Female.--Dose of cholesterol per day, 0.52 gin.  Duration of feeding, 
90 days.  Average total serum cholesterol,  334 rag. per cent.  Lipemie index, 1.7.  Ather- 
osclerosis, grade 4.  Liver fat, grade 2.  Splenic fat,  ?  Adrenal fat, grade 2.  Weight 
gain, 0.24 kilo. 
No. 28.  Control.  Female.--Dose of cholesterol per day, 0.52 gm.  Duration of feeding 
90 days.  Average total serum cholesterol,  349  mg. per cent.  Lipemic index, 2.  Athero- 
sclerosis, grade 4.  Liver fat, grade 1.  Splenic fat, grade 1.  Adrenal fat, grade 2.  Weight 
gain, 0.78 kilo. 
Inasmuch as equal daily doses of cholesterol were fed to rabbits of different 
body weights, it is conceivable that the apparent inhibitory effect of the diabetic 
state might have occurred because of the chance feeding to the non-diabetic 
animals of a higher dose of cholesterol per kilo of body weight.  In the following 
protocols the diabetic and non-diabetic animals are matched as to sex, duration 
of cholesterol feeding, average total serum cholesterol, and, in addition, as to 
dosage of cholesterol calculated as an average dose per day per kilo of average 
body weight during the feeding period.  It is apparent from examination of 
these protocols that the experimental result was not determined by actual or 
relative differences in the dosages of cholesterol. 
No. 11.  Diabetic.  Male.--Dose of cholesterol (dry) per day per kilo, 145 mg.  Duration 
of feeding, 91 days.  Average total serum cholesterol, 90 rag. per cent.  Lipemic index, 0.8. 
Atherosclerosis,  grade 0.  Liver fat, grade 0.  Splenic fat, grade 1.  Adrenal fat, normal. 
Weight loss, 0.51 kilo. 
No. 14.  Control.  Male.--Dose of cholesterol (dry) per day per kilo, 150 mg.  Duration G.  L.  DUFF AND  G.  C.  MeMILLAN  621 
of feeding,  91 days.  Average total serum cholesterol,  103 rag. per cent.  Lipemic index, 0. 
Atherosclerosis,  grade  1.  Liver fat, grade 0.  Splenic fat, grade 0.  Adrenal fat, normal. 
Weight loss, 0.08 kilo. 
No.  44.  Diabetic.  Male.--Dose  of cholesterol  per  day per  kilo,  203  rag.  Duration 
of feeding, 82 days.  Average total serum cholesterol,  1970 mg. per cent.  Lipemic index, 1.6. 
Atherosclerosis,  grade 2.  Liver fat, grade 2.  Splenic fat, grade 3.  Adrenal fat, grade 2. 
Weight gain, 0.40 kilo. 
No.  48.  "Alloxan-R~overed."  Male.--Dose  of  cholesterol  per  day  per kilo, 201  rag. 
Duration of feeding, 82 days.  Average total serum cholesterol,  1849 rag. per cent.  Lipemic 
index, 1.5.  Atherosclerosis,  grade 4.  Liver fat,  grade 4.  Splenic fat, grade 3.  Adrenal 
fat, grade 4.  Weight gain, 0.07 kilo. 
Inspection of the data presented in all the groups of protocols given above 
indicates further that gain or loss of body weight during the course of the feeding 
period exercised no determining influence on the result of the experiment. 
It may be added that it was not possible to select pairs or groups of diabetic 
and non-diabetic animals matched as in the groups detailed above that yielded 
evidence contrary to that already presented. 
Careful morphological examination,  both grossly and microscopically, of the 
aorta and other organs revealed in varying degrees, as already indicated in Table 
I, the lesions that have been described by many authors as the characteristic 
sequelae of prolonged cholesterol feeding in rabbits (2-4).  Not only were these 
lesions characteristic  in form and location in the cholesterol-fed control animals, 
but also in the "alloxan-recovered"  and diabetic rabbits.  The only distinguish- 
able difference in the morphology of the aortic lesions was a quantitative one as 
detailed above.  This was true also of the lipid deposition in the liver, spleen, 
and adrenal glands.  It should be noted, moreover,  that in those parts of the 
aorta and other arteries that were uninvolved by cholesterol atherosclerosis, no 
differences could be distinguished microscopically between the diabetic and non- 
diabetic rabbits.  The diabetic animals regularly presented the lesion of Ar- 
manni in the kidney and the hydropic changes  in the pancreatic islets  and 
ductules that have been described in detail elsewhere as characteristic of pro- 
longed alloxan diabetes  (8).  The islets of Langerhans and the pancreatic duc- 
tules in the "alloxan-recovered"  animals lacked hy'dropic changes but careful 
study of the islets  revealed  a  peculiar  and characteristic  disturbance of cell 
arrangement which was distinctly different from the normal.  However, in no 
other organ, including the thyroid gland, was there any evidence of a histologic 
difference between the diabetic,  "alloxan-recovered,"  and control animals. 
II.  TJ:t~: EFFECT OF ALLOXAN DIABETES  ON  "£kl~ RETROGRESSION OF 
EXPERIMENTAL  CHOLESTEROL ATii.EROSCLEROSIS 
Materials and Methods 
Eighty-one young, adult, domestic white rabbits of both sexes were employed.  Of these 
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Each of the 25 rabbits  in one group was fed 61.5 to 62.5 gin. of cholesterol during 88 to 90 
days.  In a second group of 7 rabbits each was fed 40.5 gin. of cholesterol during 59 days. 
The individual daily dose of cholesterol was 0.75 gin. fed by means of a stomach tube as a 
5 per cent solution in warm corn oil. 
Determinations at intervals of approximately 3 weeks were made of the non-fasting blood 
sugar, and of the free and total cholesterol content of the serum by a modified Folin micro 
method and the Schoenheimer-Sperry method respectively. 
Immediately  following the completion of the period of cholesterol feeding about one-half 
of the animals of each group received an intravenous injection of 150 rag. of alioxan per kilo 
of body weight administered as a 5 per cent aqueous solution.  No insulin or other therapy 
was employed.  The animals were given an unlimited diet of Purina rabbit chow and water 
ad libitum. 
The animals, including diabetic,  control, and those that recovered from the effects of a 
diabetogenic  dose of allox&n after  a  brief  period  of diabetes  ("alloxan-recovered"),  were 
sacrificed at intervals  of 1 to 16 weeks after the cessation of cholesterol feeding.  Complete 
autopsies were performed and the tissues were treated in the same manner as described in 
Part I  of this paper.  The criteria  of the diabetic  state and the grading of the degree of 
aortic atherosclerosis and of the amount of lipid deposited in the liver, spleen, and adrenal 
were also the same as those used in the experiment described in Part I. 
Observations 
The experimental procedures and observations are summarized in Table II, 
in which the average values of serum cholesterol given are those obtained during 
the cholesterol feeding period, including one determination made the day before 
cholesterol feeding was begun.  The blood sugar values are averages obtained 
after  the  cessation of cholesterol feeding.  Among the  animals  that were in- 
jected with alloxan, the average of the blood sugar content includes one determi- 
nation made before alloxan was administered.  The period of retrogression was 
that between the cessation of cholesterol feeding and death of the animal.  In 
the  diabetic  animals  the  duration  of diabetes  was the  same as the period of 
retrogression. 
The results as shown in Table II did not demonstrate that alloxan diabetes 
has any effect on the rate or degree of retrogression of experimental cholesterol 
atherosclerosis in the rabbit as judged by gross morphological examination of 
the aorta stained in toto with Sudan IV.  Neither did microscopic examination 
of the entire length of the aorta reveal any appreciable differences between the 
atherosclerotic lesions of comparable diabetic and non-diabetic animals.  The 
diabetic state was not found to alter appreciably the rate or degree of disap- 
pearance of abnormal lipid deposits in the liver, spleen, and adrenal cortex as 
judged by miscroscopic examination  of appropriately  stained frozen sections. 
In spite of the fact that in certain of the diabetic animals there occurred shortly 
after the administration of alloxan a distinct increase in the previously existing 
hypercbolesterolemia,  they  in  common with  the  other  diabetic  animals,  the 
control, and "alloxan-recovered" rabbits,  showed a  return of the blood choles- 
terol to normal levels within 42 days.  The only consistent biochemical differ- G.  L.  DUF]~ AND  G.  C.  MCMILLAN 
TABLE  II 
Summary  of Experimental  Data 
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Series 
3 
No.  Sex  mental 
1  F 
2  F 
3  F 
4  F 
5  F 
6  F 
7  F 
8  F 
9  F 
i0  M 
Ii  F 
12  F 
13  F  MD 
14  M  D 
15  M  AR 
16  M  AR 
17  M  AR 
18  F 
19  F 
20  F 
21  M 
22  M 
23  M 
24  F 
25  F 
26  F 
27  F 
28  F 
29  M 
3O  F 
31  F 
32  M 
q~ri, 
D 
D 
C 
D 
D 
C 
C 
D 
D 
C 
D 
C 
D 
D 
C 
C 
C 
C 
C 
C 
D 
D 
C 
C 
C 
C 
AR 
Total 
dose of 
:holesterc 
&m. 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
62.2.  ~ 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
61.5 
40.5 
40.5 
40.5 
40.5 
40.5 
40.5 
40.5 
I 
Time of  bloo~  Average  Average  [Aortic ath- 
Avera e 
retro-  sugar  free serum ltotal seram[erosclerosis 
gression  during ret- cholesterol cholesterol  (0-4) 
__  rogress,o_____~n  ,  "t 
.s.  [  rag. per  mg. per  rag. per  ] 
.....  cent  '  ",cat  I  ¢~t  I 
11 
16 
m 
570 
122 
357 
384 
134 
148 
319 
425 
121 
353 
121 
286 
410 
138 
175 
163 
396 
488 
133 
126 
120 
111 
124 
127 
3O9 
373 
130 
120 
128 
125 
124 
90  277  ! 
134  382  4 
174  398  3 
163  471  3 
144  426  2 
161  516  4 
107  291  3 
194  472  4 
96  307  3 
106  261  2 
140  440  4 
135  430  3 
218  525  4 
124  318  2 
81  208  4 
163  487  2 
183  479  2 
232  480  2 
83  298  4 
126  371  4 
88  325  2 
143  382  4 
72  240  3 
140  320  3 
88  262  3 
138  424  4 
41  187  3 
145  452  3 
71  214  2 
83  270  4 
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ence observed  between  the various groups  of rabbits was the hyperglycemic 
state of the diabetic animals.  The only morphological  differences found to 
exist between diabetic and non-diabetic  animals were the changes in the pan- 
creas and kidney that are associated with the injection of alloxan or with the 
development of persistent diabetes. 
In both the diabetic and non-diabetic animals there was no gross morphologi- 
cal evidence that any appreciable retrogression of the aortic atherosclerosis had 
occurred  during periods  of up to 4 months' duration.  However,  in animals 
that survived a period of retrogression  of 6 weeks or more there was definite 
microscopic evidence of the disappearance of lipid deposits from the aorta, splenic 
arterioles,  and other small arteries,  from the reticulo-endothelial  cells of  the 
liver and spleen, and from the parenchymal cells of the liver and adrenal cortex. 
In the aorta, the gradual disappearance of lipid material was accompanied by a 
gradual increase in the number of fibroblastic ceils in the atherosclerotic lesions. 
DISCUSSION 
The observations  recorded in Part I of this paper demonstrate clearly that, 
under the conditions described, there was associated with the presence of alloxan 
diabetes a marked but incomplete inhibition of the development of experimental 
cholesterol atherosclerosis in cholesterol-fed rabbits.  There was also an inhibi- 
tion of the deposit of sudanophilic lipid substances  in the reticulo-endothelial 
cells of the liver and spleen and in the parenchymal cells of the liver and adrenal 
cortex.  This inhibition occurred in spite of the induction of a marked degree 
of hypercholesterolemia in many of the diabetic animals, hypercholesterolemia 
that was usually as high as, and often higher than, that observed in the corre- 
sponding control animals. 
This inhibitory effect was apparently dependent neither upon the administra- 
tion of alloxan per se nor upon the short initial period of insulin and dextrose 
therapy,  inasmuch  as  both  the  diabetic  and  "alloxan-recovered"  animals 
received such injections before cholesterol feeding was instituted, but only in 
the diabetic rabbits was the inhibitory effect apparent.  The "alloxan-recov- 
ered" animals responded to cholesterol feeding exactly as did the control ani- 
mals.  In addition, it was found that the inhibitory effect was not dependent 
on the sex or weight of the animal, nor upon the daffy dosage of cholesterol, the 
form in which it was administered, nor the duration of cholesterol feeding.  The 
effect was also independent of changes in body weight occurring  during the 
course of our experiments and of the actual degree of hypercholesterolemia  in- 
duced by the administration of cholesterol.  Moreover,  there was no gross or 
histological evidence of a morphological basis for the inhibitory effect either in 
the aorta or in the other organs in which it was observed.  Indeed, the only 
observed  factors consistently associated  with the inhibition of the expected 
morphological effects of cholesterol feeding were the diabetic state and a degree G.  L.  DUFF  AND  G.  C.  McMILLAN  625 
of visible lipemia considerably greater than that observed in the control animals. 
A moderate degree of visible lipemia in the control animals was regularly asso- 
ciated with the development of severe atherosclerosis of the aorta.  On the con- 
trary, a marked degree of visible lipemia was observed in a large proportion of 
the diabetic animals that presented at autopsy only a minimal degree of aortic 
atherosclerosis. 
Objection might possibly be  raised  to our inference that  the injection of 
alloxan per se, apart from its diabetogenic effects, was not responsible for the 
inhibitory effect observed  in  the  diabetic  animals  on  the  ground  that  the 
"alloxan-recovered" rabbits did not provide a valid control of this possible fac- 
tor.  It could be argued that the "alloxan-recovered" animals were less sus- 
ceptible to the general effects of alloxan than the diabetic animals as indicated 
by the very fact that permanent diabetes failed to develop in them.  Animals 
that fail to respond with the development of permanent diabetes to a  dose of 
alloxan that is diabetogenic to a majority of the species are frequently referred 
to  in  the  literature  rather  loosely as  "alloxan-resistant."  However,  in  our 
"alloxan-recovered" animals, the diabetogenic effect of alloxan was manifested 
initially in the production of a  temporary diabetic state of mild or moderate 
severity from which spontaneous recovery occurred within the period of several 
weeks before cholesterol feeding was started.  Clearly, the injection of alloxan 
was effective, at least  to  a  degree, but  these particular rabbits  displayed a 
capacity for recovery that distinguished them from the permanently diabetic 
animals. 
Although we have referred to these animals as "alloxan-recovered" there is 
reason to believe that such animals have not returned to a strictly normal state. 
In our present observations, the "alloxan-recovered" animals during the period 
of cholesterol feeding showed neither obvious nor chemical evidence of diabetes. 
However,  in  other  experiments  (9)  more  detailed and precise  studies  have 
demonstrated that alimentary glycosuria may be present in such animals in 
spite of normal fasting blood sugar levels and that this is dependent on the oc- 
currence  of  slight  postprandial  hyperglycemia.  These  residual  metabolic 
defects are correlated with the presence of definite histological alterations in the 
islets of Langerhans which were detectable in the animals of our present experi- 
ments months after the injection of alloxan. 
There is ample evidence, therefore, to indicate that our "alloxan-recovered" 
animals did not tolerate the  injection of alloxan without suffering from its 
effects.  Accordingly, we are inclined to regard these animals, at least tenta- 
tively, as providing a suitable control of the effects of alloxan injection per se. 
Further experiments currently in progress  are  designed to  settle this point 
definitely by determining whether the inhibitory effect observed in alloxan- 
diabetic rabbits is abolished by controlling the diabetic state with insulin. 
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effect observed in the present experiments, it would appear, in view of the con- 
siderations set forth in the preceding paragraphs,  that  it is dependent upon 
some undefined factor or factors implicit  in,  or closely associated with,  the 
diabetic  state.  That  the  diabetic  condition  or  factors  associated  with  it 
exercised an influence on the state and stability of the blood lipids in rabbits fed 
cholesterol  in oil is indicated not only by the development of a marked visible 
lipemia, but also by the inhibition of lipid deposition in the aorta and elsewhere. 
Since the deposition of lipids in the intima of arteries is an essential feature of 
the development of experimental cholesterol  atherosclerosis,  particular interest 
attaches to any evidence of an alteration of the physicochemical state of the 
lipids in the blood plasma (dz. excessive lipemia) that coexists with protection 
from the usual effects on the arteries of rabbits associated with hypercholes- 
terolemia.  1 
Almost from the first demonstration of the fact that the feeding of cholesterol 
is capable of producing atherosclerosis  in the arteries of rabbits  (10),  it was 
recognized  that the development of the arterial lesions is associated with a sig- 
nificant elevation of the cholesterol  content of the blood  (11).  This was con- 
firmed  repeatedly by subsequent studies which showed that,  in  general,  the 
severity of the induced atherosclerosis  is correlated with the degree and  dura- 
tion of the induced state of hypercholesterolemia (2--4).  It has also been shown 
that  the  development of experimental  cholesterol  atherosclerosis  can  be in- 
hibited by various modifications  of the experimental procedure  that  prevent 
the development of the expected degree  of hypercholesterolemia  (3, 4).  On 
the basis of such data, the concept arose that hypercholesterolemia is the sole 
factor of importance in the genesis of experimental atherosclerosis.  This con- 
cept was seriously questioned some years ago by Duff (3) on the basis of the 
evidence then available and,  more recently, certain other investigators have 
emphasized that factors other than hypercholesterolemla may be important in 
the development of experimental atherosclerosis,  pointing out that animals with 
comparable levels  of induced hypercholesterolemia frequently exhibit widely 
differing degrees of atherosclerosis  (12-15). 
The  absolute  inhibition  of  the  development  of  experimental  cholesterol 
atherosclerosis  in an appreciable number of the diabetic rabbits in our experi- 
ments in spite of the presence of marked and prolonged hypercholesterolemia 
shows clearly that the mere existence of a markedly increased quantity of cho- 
lesterol in the circulating blood for a considerable  length of time is not in itself 
capable of causing lesions in the arteries.  This conclusion is supported by the 
demonstration of Steiner (16, 17) and others (18, 19) that the addition of cho- 
line  to the diet inhibits  the development of atherosclerosis  in cholesterol-fed 
z This evidence clearly conflicts with the hypothesis of Moreton (Science,  1947, ].06,  190; 
and 1948, ].07, 371) which postulates that the determining factor in the development of ath- 
erosclerosis is the presence in the circulating blood of lipid particles of large size such as are 
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rabbits, though it does not prevent the development of marked hypercholes- 
terolemia  (16, 17).  It is evident, therefore, that the development of experi- 
mental cholesterol atherosclerosis  is dependent not only upon the occurrence of 
hypercholesterolemia per se but also upon another  essential factor or factors 
as yet undetermined. 
We are fully aware that our experimental observations are at variance with 
the evidence adduced to show that diabetes mellitus in man promotes the de- 
velopment of arteriosclerosis.  A  logical  resolution of this  apparent  conflict 
compels consideration of one or more of the following possibilities.  First, the 
conflict may be consequent on species differences.  Second, alloxan diabetes in 
the rabbit may not be metabolically comparable with diabetes mellitus in man. 
Third, experimental cholesterol  atherosclerosis  in rabbits may not be compa- 
rable with  the type of arterial disease to which diabetic patients  are prone. 
Fourth, the impression  that occlusive arterial disease in diabetic patients is de- 
pendent  upon  an  excessive  development of atherosclerosis  of the  intima  of 
arteries may be erroneous.  Obviously, it is impossible  in the present state of 
knowledge to predict which of the possibilities  just mentioned may prove to be 
correct. 
The experimental data presented in Part II of this paper clearly fail to demon- 
strate any difference  in the rate  of retrogression of experimental  cholesterol 
atherosclerosis  in alloxan-diabetic rabbits as compared with control animals. 
In our experiments the period of retrogression,  i.e. the period after the feeding 
of cholesterol was terminated, was limited to 4 months.  Whether experiments 
with longer periods of retrogression would show any differential effect is impos- 
sible  to  say.  More  prolonged  experiments,  however,  would  be  technically 
difficult because of the excessive mortality from alloxan  diabetes of long dura- 
tion in rabbits. 
Our negative results are similar to those reported by other investigators who 
have attempted to influence the retrogression of experimental cholesterol athero- 
sclerosis by the administration  of potassium iodide  (20,  21).  On  the  other 
hand, Steiner (22) some years ago brought forward highly suggestive evidence 
of the ability of choline to bring about some reabsorption of arterial lesions pre- 
viously induced by cholesterol  feeding.  Added to this evidence is the recent 
report of Morrison and Rossi (23) who have described complete reabsorption 
of the lesions of experimental cholesterol  atherosclerosis  in 17 out of 23 rabbits 
given larger daily doses of choline over a period of 182 days after the cessation 
of cholesterol  feeding. 
The observations, already cited relative to the effects of choline on the devel- 
opment and retrogression of experimental cholesterol  atherosclerosis,  coupled 
with the results of our own experiments on the effects associated with the pres- 
ence of alloxan diabetes, permit of interesting deductions regarding the process 
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all the observations are correct and correctly interpreted, it is evident that the 
process of lipid accumulation must represent the resultant of the effects of two 
separate and distinct sets of factors, those factors the balance of which hinders 
or promotes the deposit of lipids in the arterial walls, and another set of factors 
the balance of which hinders or promotes their removal after they are deposited. 
This is not a new concept but the means of demonstrating its correctness have 
not hitherto been available.  Since alloxan diabetes (or some associated influ- 
ence) inhibits the development of experimental cholesterol atherosclerosis but 
has no noticeable effect on the retrogression of the arteriaHesions, it follows that 
the inhibitory effect must be implemented solely or almost solely by interference 
with the deposit of lipids.  On the other hand, the results of Morrison and 
Rossi (23) indicate that the administration of choline has a powerful effect in 
facilitating the removal of lipids already deposited in the arterial wall.  The 
effect of choline in inhibiting the development of experimental cholesterol ather- 
sclerosis,  as described by Steiner (17) could, therefore, be due either to inter- 
ference with the deposition of lipids, or to facilitation of their removal as rapidly 
as they are deposited or to a combination of both effects.  However, if choline 
facilitates the removal of lipids already deposited in the arterial walls, this is 
the only effect of choline on experimental atherosclerosis that is susceptible of 
proof by the types of experiment under consideration here.  The mechanisms 
of interference with the deposit of lipids and of facilitation of their removal re- 
main to be investigated and clarified but the means to do so appear now to be 
at hand. 
It is evident that our experimental results find no direct application to the 
problem of arterial disease in human diabetes.  Nevertheless, if it is true that 
the accumulation of lipids in the intima of arteries is a central feature of human 
atherosclerosis, as it appears to be of experimental cholesterol atherosclerosis, 
then the isolation of the factors governing this fundamental biological process 
in the experimental animal may be expected to help in elucidating the nature of 
the same process in man. 
SUMMARY 
A comparison was made of the effects of cholesterol feeding in normal rabbits 
and in rabbits rendered persistently diabetic by means of alloxan.  In the two 
groups of animals hypercholesterolemia of comparable degree was induced by 
the feeding procedure.  Nevertheless, the severity of the atherosclerosis of the 
aorta produced in the diabetic rabbits was much less than in the non-diabetic 
control animals.  Indeed, a large proportion of the diabetic animals presented 
no atherosclerosis whatever.  There was a similar inhibition of the deposit of 
lipid substances in the liver, spleen, and adrenal glands of the diabetic rabbits. 
The inhibition of the development of experimental cholesterol atherosclerosis 
which was associated with the presence of aUoxan diabetes was independent of G.  L.  DUFF  AND  G.  C.  McMILLAN  629 
the administration of alloxan per se.  It was not dependent on the sex or weight 
of the animal, nor upon the daily dosage of cholesterol, the form in which it was 
administered, nor the duration of cholesterol feeding.  It was also independent 
of changes in body weight occurring during the course of our experiments and 
of the actual degree of hypercholesterolemia induced by the administration of 
cholesterol.  In addition, there was no gross or histological evidence of a mor- 
phological basis for the inhibitory effect either in the aorta or in the other organs 
in which it was observed. 
Only two factors were observed to be consistently associated with the inhibi- 
tion of the expected morphological effects of cholesterol feeding, namely, the 
diabetic state and a  degree of visible lipemia considerably greater than that 
observed in the control animals. 
The inhibitory effect observed in these experiments would appear to depend 
upon some as yet undetermined factor or factors implicit in the diabetic state 
or closely associated with it.  The experimental data presented demonstrate 
clearly that hypercholesterolemia is not the sole factor concerned in the genesis 
of experimental cholesterol atherosclerosis, but that another factor, or factors, 
rendered inoperative in our experiments must be essential to the production of 
the arterial lesions. 
In view of the inhibitory effect on the development of experimental cholesterol 
atherosclerosis observed in alloxan-diabetic rabbits, the effect of alloxan dia- 
betes on the retrogression of such arterial lesions was studied in another series of 
experiments.  No effect on retrogression could be demonstrated within periods 
lasting up to a maximum of 4 months after the cessation of cholesterol feeding. 
The results of our two series of experiments, considered together, indicate 
that the process of deposition of lipids in the arterial walls is governed by factom 
different from those that are operative in the process of removal of lipids after 
they have been deposited.  The inhibition of the development of experimental 
chllesterol atherosclerosis in alloxan-diabetic rabbits must depend on interfer- 
ence with the process of deposition of lipids and not on a process of removal of 
lipids as fast as they are deposited. 
Our experimental results find no direct application to the problem of arterial 
disease in human diabetes.  Nevertheless,  the experimental procedures  that 
we have employed provide a  new basis for the design of further experiments 
directed  toward  the  elucidation of the nature of the  unknown factors  that 
govern the process of lipid deposition in the wails of arteries. 
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